Michael Burry Stock Portfolio: 6 Stocks to Buy

4. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Scion Asset Management Equity Stake: $7.88 Million

Stock Performance (end Q2-October 9): 5.4%

Number of Hedge Fund Holders: 73

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the top stocks to buy in Michael Burry’s stock portfolio. On October 6, the company announced it is poised to incur an $83 million in-process research and development (IPR&D) charge.

The charge is related to an $80 million up-front payment made to Hansoh Pharmaceuticals Group Company Limited as part of a 2025 license agreement. In addition to up-front, opt-in, and some development milestone payments, acquired IPR&D charges may also include milestone payments and premiums paid on equity securities associated with licensing and partnership agreements.

The charge is expected to reduce the company’s GAAP and non-GAAP net income per diluted share by about $0.68 in the third quarter.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is a biotechnology company that discovers, develops, manufactures, and commercializes medicines for serious and rare diseases, including eye diseases, cancer, neurological conditions, inflammatory and allergic diseases, and cardiovascular diseases.